Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFree online semaglutide training courses do exist (aimed mainly at healthcare professionals wanting to understand GLP-1 medicines) but they are educational tools, not a route to prescribing or obtaining Wegovy for yourself. Semaglutide (Wegovy) is a Prescription-Only Medicine in the UK, meaning clinical assessment by a registered prescriber is required before treatment can begin. This page covers what these courses actually teach, who they are designed for, and where to find accurate clinical information if you are a patient exploring Wegovy as a weight-loss treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The scientific case for semaglutide in weight management rests on a tightly controlled clinical programme. The STEP 1 trial randomised nearly 2,000 adults with obesity and followed them for 68 weeks, finding an average weight reduction of around 15% on the 2.4mg weekly dose, figures that fed directly into NICE's appraisal and the UK licence. The full STEP 1 paper, published in the New England Journal of Medicine, is publicly accessible and remains the most-cited source for patients and professionals alike.
Free online training courses emerged partly because that evidence base is complex. A GLP-1 receptor agonist slows gastric emptying, acts on appetite-regulating centres in the brain, and (in semaglutide's case) stimulates a single receptor pathway. Nurses, GPs and pharmacists completing these modules learn injection technique supervision, dose-escalation rationale, and how to manage side effects in a clinical context. The courses are grounded in the same regulatory science; they just require a professional lens to apply it safely.
One misconception worth setting aside gently: completing a free online module does not make it appropriate to source or administer semaglutide outside a prescriber relationship. If you have come across references to semaglutide peptide available online, it is worth understanding that the medicine's mechanism is the same regardless of who reads about it, but the safety net around clinical assessment, contraindication screening and ongoing monitoring is not something a training module replaces. Worth knowing before starting the search.
Most free online semaglutide courses sit within professional development platforms: NHS Learning Hub resources, pharmacist CPD modules, Royal Pharmaceutical Society guidance documents, and manufacturer-supported e-learning (Novo Nordisk's own healthcare professional portal, for example). They assume the learner already has prescribing authority or works under one. Topics typically include patient selection criteria, the titration schedule and why it exists, injection site rotation, and recognition of side effects requiring clinical escalation.
Patients researching semaglutide will find these resources informative (the mechanism sections in particular are well-written) but they are not structured as a patient guide, and they will not answer questions about personal eligibility or suitability. The NHS medicines page for semaglutide is a better starting point for patients: it covers what the medicine is, how it is given, what side effects to watch for, and when to seek help, in clear plain-English format.
If you are a healthcare professional looking for a structured UK accredited programme, a UK-based semaglutide training course will take you further than a free module, with formal assessment and CPD certification that employers and regulators recognise.
Accessing Wegovy legally in the UK requires a prescription, and that prescription requires a full clinical assessment. No amount of background reading changes that, nor should it. The assessment matters because semaglutide has a meaningful contraindication list: personal or family history of medullary thyroid carcinoma, MEN2, certain gastrointestinal conditions, and several drug interactions all need to be screened before treatment is appropriate. The prescriber also establishes the starting dose, maps out the titration plan, and monitors progress.
On the NHS, Wegovy is available through specialist weight management services under NICE TA875, which recommends it for adults with a BMI of 35 or above (lower thresholds apply for some ethnic backgrounds) alongside at least one weight-related comorbidity, and for a maximum of two years. Waiting lists for those services are long in many areas. For context on what private treatment involves, our guide to accessing Wegovy online covers the legitimate private route step by step, including what a clinical consultation looks like and how verification works.
Cost is a genuine consideration. For a plain account of what private semaglutide treatment typically costs in the UK and what that price should include, the Wegovy cost and pricing page sets out the market honestly.
One area where both professional training resources and the clinical trial literature agree: semaglutide works best as part of a broader lifestyle programme, not as a standalone intervention. NICE TA875 frames it explicitly as an adjunct to reduced-calorie diet and increased physical activity. The STEP 1 trial provided all participants with lifestyle counselling alongside the medicine.
Practically, that raises a question many patients ask, how does semaglutide interact with structured exercise, and specifically resistance training? The concern about muscle loss during rapid weight reduction is legitimate and well-discussed in the clinical literature. Our page on weight training on semaglutide covers what the evidence currently says about preserving lean mass during treatment. It is one of the more useful things to understand before starting, and it is not typically covered in standard semaglutide professional training modules, which focus on clinical safety rather than patient lifestyle optimisation.
If you are at the stage of asking whether semaglutide is right for you personally, a prescriber's review is the next step. Our prescribers at nume review every consultation the same day it is submitted, a real clinician reads it, not a queue management algorithm. If clinically suitable, treatment is dispatched the same working day and arrives with tracked next-day delivery. You can start your free consultation here if you'd like a clinical view of whether Wegovy is appropriate for your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.